| 注册
首页|期刊导航|中国药理学通报|ADAM8在恶性肿瘤转移中的作用研究进展

ADAM8在恶性肿瘤转移中的作用研究进展

贾琦 刘兆国 余苏云 陈力川 祝娉婷 陈文星 王爱云 陆茵

中国药理学通报2017,Vol.33Issue(8):1037-1040,4.
中国药理学通报2017,Vol.33Issue(8):1037-1040,4.DOI:10.3969/j.issn.1001-1978.2017.08.001

ADAM8在恶性肿瘤转移中的作用研究进展

Role of ADAM8 in tumor metastasis

贾琦 1刘兆国 2余苏云 1陈力川 2祝娉婷 1陈文星 2王爱云 1陆茵2

作者信息

  • 1. 南京中医药大学药学院,江苏 南京 210023
  • 2. 江苏省中药药效与安全性评价重点实验室,江苏 南京 210023
  • 折叠

摘要

Abstract

Tumor metastasis is one of the important biological characteristics of malignant tumor,which is closely related with the prognosis of the cancer patients.High expression of ADAM8 in varieties of tumors was revealed in many recent studies,and such aberrant expression played a crucial role in regulating of tumor metastasis.Studies showed that overexpression of ADAM8 attenuated the intercellular adhesion effect,promoted tumor angiogenesis,and enhanced the degradation of ECM as well as the releasing of cytokines.Therefore,suppression of ADAM8 may lead to inhibition of tumor metastasis,which makes ADAM8 a particular attractive target as it can be used as a prognostic indicator and a potential therapeutic target of malignant tumor.A review about the relations between ADAM8 protein′s abnormal expression and tumor occurrence was discussed in this paper,also include discussion about the mechanisms of ADAM8 protein′s disorder-induced tumor formation,as well as therapeutic strategies based on ADAM8-targeted,which may provide references for follow-up research and clinical treatment.

关键词

肿瘤/肿瘤转移/去整合素-金属蛋白酶8/ECM/作用机制/治疗策略

Key words

tumor/tumor metastasis/a disintegrin and metalloproteinase 8/ECM/mechanisms/therapeutic strategy

分类

医药卫生

引用本文复制引用

贾琦,刘兆国,余苏云,陈力川,祝娉婷,陈文星,王爱云,陆茵..ADAM8在恶性肿瘤转移中的作用研究进展[J].中国药理学通报,2017,33(8):1037-1040,4.

基金项目

国家自然科学基金项目资助 (No 81673725,81673648,81573859) (No 81673725,81673648,81573859)

江苏省自然科学基金资助项目(No BK2012854) (No BK2012854)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文